#2716 on the rich list of 14,644 insiders
Murat Kalayoglu
10% owner at Cartesian Therapeutics. Based in Washington, Washington, D.C..
$45.5M
in disclosed stock, −$3.2M (−6.51%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 2716th of 14,644
- Companies held
- 1
- Largest holding
- RNAC, 100.0% of total
- Latest SEC filing
- Apr 2, 2026
What the $45.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Cartesian Therapeutics RNAC Common Stock | Through trust | 4,555,260 | $5.89 | $26.8M | 59.0% | Form 4, Jan 2, 2026 |
| Cartesian Therapeutics RNAC Common Stock | Through trust Reported jointly by 2 insiders; split evenly | 2,656,631 | $5.89 | $15.6M | 34.4% | Form 4, Apr 2, 2026 |
| Cartesian Therapeutics RNAC Common Stock | Directly | 506,999 | $5.89 | $3.0M | 6.6% | Form 4, Apr 2, 2026 |
Share counts are the amounts Murat Kalayoglu reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2713 | Nangeng Zhang Chief Executive Officer, Canaan | $45.5M |
| 2714 | Erez Shachar Director, Riskified. New York, NY | $45.5M |
| 2715 | John L. Stauch President & CEO, Pentair. Minneapolis, MN | $45.5M |
| 2716 | Murat Kalayoglu 10% owner, Cartesian Therapeutics. Washington, DC | $45.5M |
| 2717 | Scott M. Sperling Director, Thermo Fisher Scientific. Boston, MA | $45.4M |
| 2718 | Matthew P. Flake Chief Executive Officer, Q2 Holdings. Austin, TX | $45.4M |
| 2719 | Jason W. Fraser EVP & CFO, Valero Energy. San Antonio, TX | $45.4M |
Other Cartesian Therapeutics insiders
All RNAC insiders- Timothy A. Springer$52.9MDirector. #1111 overall
- Elizabeth Hoge$15.6M10% owner. #6212 overall
- Timothy C. Barabe$336KDirector. #9717 overall
- Carrie Smith Cox$92KDirector. #4398 overall
- Patrick Zenner$76KDirector. #6132 overall
Questions
How much stock does Murat Kalayoglu own?
Murat Kalayoglu holds $45,464,259 in listed stock based on SEC filings and current prices, mostly Cartesian Therapeutics (RNAC). That ranks 2716th on the Stock Rich List.
Is this Murat Kalayoglu's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.